{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T23:24:08Z","timestamp":1742945048754,"version":"3.40.3"},"publisher-location":"Cham","reference-count":20,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319707716"},{"type":"electronic","value":"9783319707723"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-70772-3_29","type":"book-chapter","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T02:58:27Z","timestamp":1509677907000},"page":"304-311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Using Knowledge Graph for Analysis of Neglected Influencing Factors of Statin-Induced Myopathy"],"prefix":"10.1007","author":[{"given":"Yu","family":"Yang","sequence":"first","affiliation":[]},{"given":"Zhisheng","family":"Huang","sequence":"additional","affiliation":[]},{"given":"Yong","family":"Han","sequence":"additional","affiliation":[]},{"given":"Xiaoli","family":"Hua","sequence":"additional","affiliation":[]},{"given":"Weijing","family":"Tang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,11,4]]},"reference":[{"issue":"3","key":"29_CR1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.acvd.2014.01.011","volume":"107","author":"E Bruckert","year":"2014","unstructured":"Bruckert, E., Ferri\u00e8res, J.: Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice. Arch. Cardiovasc. Dis. 107(3), 188\u2013200 (2014)","journal-title":"Arch. Cardiovasc. Dis."},{"key":"29_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/bmj.g3743","volume":"349","author":"CS Desai","year":"2014","unstructured":"Desai, C.S., Martin, S.S., Blumenthal, R.S.: Non-cardiovascular effects associated with statins. BMJ 349, 37\u201343 (2014)","journal-title":"BMJ"},{"issue":"3","key":"29_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jacl.2012.03.003","volume":"6","author":"JD Cohen","year":"2012","unstructured":"Cohen, J.D., Brinton, E.A., Ito, M.K., Jacobson, T.A.: Understanding statin use in america and gaps in patient education (usage): An internet-based survey of 10,138 current and former statin users. J. Clin. Lipidol. 6(3), 208\u2013215 (2012)","journal-title":"J. Clin. Lipidol."},{"key":"29_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.atherosclerosis.2015.12.015","volume":"245","author":"GK Hovingh","year":"2016","unstructured":"Hovingh, G.K., Gandra, S.R., Mckendrick, J., et al.: Identification and management of patients with statin-associated symptoms in clinical practice: a clinician survey. Atherosclerosis 245, 111\u2013117 (2016)","journal-title":"Atherosclerosis"},{"issue":"8","key":"29_CR5","doi-asserted-by":"publisher","first-page":"e42866","DOI":"10.1371\/journal.pone.0042866","volume":"7","author":"KB Hoffman","year":"2012","unstructured":"Hoffman, K.B., Kraus, C., Dimbil, M., et al.: A survey of the FDA\u2019s AERS database regarding muscle and tendon adverse events linked to the statin drug class. PLoS ONE 7(8), e42866 (2012)","journal-title":"PLoS ONE"},{"issue":"4","key":"29_CR6","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1177\/2047487314525531","volume":"21","author":"JA Finegold","year":"2014","unstructured":"Finegold, J.A., Manisty, C.H., Goldacre, B., Barron, A.J., Francis, D.P.: What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice. Eur. J. Prev. Cardiol. 21(4), 464\u2013474 (2014)","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"1","key":"29_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/2047487314550804","volume":"23","author":"J Auer","year":"2016","unstructured":"Auer, J., Sinzinger, H., Franklin, B., et al.: Muscle- and skeletal-related side-effects of statins: tip of the iceberg? Eur. J. Prev. Cardiol. 23(1), 88\u2013110 (2016)","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"11","key":"29_CR8","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/phar.1496","volume":"34","author":"R Liang","year":"2014","unstructured":"Liang, R., Borgundvaag, B., Mcintyre, M., et al.: Evaluation of the reproducibility of the naranjo adverse drug reaction probability scale score in published case reports. Pharmacotherapy 34(11), 1159\u20131166 (2014)","journal-title":"Pharmacotherapy"},{"issue":"2","key":"29_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10557-017-6723-4","volume":"31","author":"RS Rosenson","year":"2017","unstructured":"Rosenson, R.S., Miller, K., Bayliss, M., et al.: The statin-associated muscle symptom clinical index (sams-ci): revision for clinical use, content validation, and inter-rater reliability. Cardiovasc. Drugs Ther. 31(2), 179\u2013186 (2017)","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"7","key":"29_CR10","first-page":"35","volume":"32","author":"GB Mancini","year":"2016","unstructured":"Mancini, G.B., Baker, S., Bergeron, J., et al.: Diagnosis, prevention, and management of statin adverse effects and intolerance: canadian consensus working group update (2016). J. Cardiol. 32(7), 35\u201365 (2016)","journal-title":"J. Cardiol."},{"key":"29_CR11","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent, C., et al.: Cholesterol treatment trialists\u2019 (CTT) collaborators. efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366, 1267\u20131278 (2005)","journal-title":"Lancet"},{"key":"29_CR12","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1161\/CIRCULATIONAHA.106.624890","volume":"114","author":"A Kashani","year":"2006","unstructured":"Kashani, A., Phillips, C.O., Foody, J.M., et al.: Risks associated with statin therapy. a systematic overview of randomized clinical trials. Circulation 114, 2788\u20132797 (2006)","journal-title":"Circulation"},{"issue":"1","key":"29_CR13","first-page":"22","volume":"346","author":"L Anekwe","year":"2013","unstructured":"Anekwe, L.: Most patients who stop taking a statin are not intolerant, suggests study. BMJ 346(1), 22\u201336 (2013)","journal-title":"BMJ"},{"issue":"37","key":"29_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/MD.0000000000001268","volume":"94","author":"Q Hou","year":"2015","unstructured":"Hou, Q., Li, S., Li, L., et al.: Association between SLCO1B1 gene T521C polymorphism and statin-related myopathy risk: a meta-analysis of case-control studies. Medicine 94(37), 12\u201368 (2015)","journal-title":"Medicine"},{"issue":"6","key":"29_CR15","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/bcp.13207","volume":"83","author":"HH Lee","year":"2017","unstructured":"Lee, H.H., Ho, R.H.: Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1). Br. J. Clin. Pharmacol. 83(6), 1176\u20131184 (2017)","journal-title":"Br. J. Clin. Pharmacol."},{"key":"29_CR16","doi-asserted-by":"crossref","unstructured":"SEARCH Collaborative Group, Link, E., Parish, S., Armitage, J., et al.: SLCO1B1 variants and statin-induced myopathy\u2014a genomewide study. N. Engl. J. Med. 359 (8), 789\u2013799 (2008)","DOI":"10.1056\/NEJMoa0801936"},{"issue":"11","key":"29_CR17","first-page":"391","volume":"74","author":"EW Schmidt","year":"1979","unstructured":"Schmidt, E.W., Bender, W.: Sensitivity of creatine kinase and creatine kinase MB in myocardial infarction. evaluation of a new optimized standard method. Med. Klin. 74(11), 391\u2013395 (1979)","journal-title":"Med. Klin."},{"issue":"9","key":"29_CR18","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/0002-9149(88)90650-9","volume":"62","author":"JE Brush Jr","year":"1988","unstructured":"Brush Jr., J.E., Brand, D., Acampora, D., Goldman, L., Cabin, H.S.: Relation of peak creatine kinase levels during acute myocardial infarction to presence or absence of previous manifestations of myocardial ischemia (angina pectoris or healed myocardial infarction). Am. J. Cardiol. 62(9), 534\u2013537 (1988)","journal-title":"Am. J. Cardiol."},{"key":"29_CR19","series-title":"Lecture Notes in Computer Science","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-3-319-26585-8_4","volume-title":"Knowledge Representation for Health Care","author":"Z Huang","year":"2015","unstructured":"Huang, Z., Hu, Q., ten Teije, A., van Harmelen, F.: Identifying evidence quality for updating evidence-based medical guidelines. In: Ria\u00f1o, D., Lenz, R., Miksch, S., Peleg, M., Reichert, M., ten Teije, A. (eds.) KR4HC 2015. LNCS, vol. 9485, pp. 51\u201364. Springer, Cham (2015). doi:10.1007\/978-3-319-26585-8_4"},{"issue":"7","key":"29_CR20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.7326\/L14-5019-2","volume":"161","author":"TR Joy","year":"2014","unstructured":"Joy, T.R., Zou, G.Y., Mahon, J.L.: N-of-1 (single-patient) trials for statin-related myalgia. Ann. Intern. Med. 161(7), 531\u2013532 (2014)","journal-title":"Ann. Intern. Med."}],"container-title":["Lecture Notes in Computer Science","Brain Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-70772-3_29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T18:21:41Z","timestamp":1710267701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-70772-3_29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319707716","9783319707723"],"references-count":20,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-70772-3_29","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"4 November 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"BI","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Conference on Brain Informatics","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Beijing","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"China","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2017","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"16 November 2017","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"18 November 2017","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"brain2017","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"http:\/\/bii.ia.ac.cn\/bi-2017\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}}]}}